The Orakl Oncology techbio platform partners with the oncology industry to meet the challenge of personalized medicine.
Our tumour models mimic real-life responses to drugs. They result from the exclusive know-how from more than 28 years of combined R&D.
Image credit to the Jaulin lab (S. Bedja, J. Cartry, E. Gontran, JB. Lopez)
We match our tumour models with detailed clinical and omics data. This provides the necessary context to interpret biological results.
We gather unique insights by mining multi-modal experimental data and combining it with deep patient data.
Fanny
Jaulin, PhD
CEO & CSO
Weill Medical College 🇺🇸, MSKCC 🇺🇸, Inserm 🇫🇷, Gustave Roussy 🇫🇷, HEC 🇫🇷
Fanny is an experienced researcher and lab-leader with more than 20 years of research in cancer biology under her belt. She is excited by anything new provided that it can positively impact society and that she can listen to Daft Punk with her children.
Diane-Laure
Pagès, PhD
COO
Ecole polytechnique 🇫🇷, Ecole Normale Supérieure 🇫🇷, Gustave Roussy 🇫🇷, HEC 🇫🇷
Diane-Laure is an interdisciplinary engineer and researcher specialized in cancer biology. Her contributions have been recognized by multiple awards. Open-minded and well-organized, she cements the team and loves sailing, whatever the weather.
Gustave
Ronteix, PhD
CTO
Ecole polytechnique 🇫🇷, Cambridge University 🇬🇧, Institut Pasteur 🇫🇷
Gustave is passionate about automating biology. He's an engineer and a researcher specialized in microfluidics, immuno-oncology and quantitative biology. He enjoys socials with colleagues and friends before heading to the rugby pitch.
